Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHUKRA PHARMA vs BACIL PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHUKRA PHARMA BACIL PHARMA SHUKRA PHARMA/
BACIL PHARMA
 
P/E (TTM) x 19.3 -90.7 - View Chart
P/BV x 14.1 7.8 180.3% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 SHUKRA PHARMA   BACIL PHARMA
EQUITY SHARE DATA
    SHUKRA PHARMA
Mar-23
BACIL PHARMA
Mar-23
SHUKRA PHARMA/
BACIL PHARMA
5-Yr Chart
Click to enlarge
High Rs8910 916.3%   
Low Rs114 303.0%   
Sales per share (Unadj.) Rs53.70-  
Earnings per share (Unadj.) Rs4.0-0.2 -2,321.9%  
Cash flow per share (Unadj.) Rs5.7-0.2 -3,389.5%  
Dividends per share (Unadj.) Rs0.500-  
Avg Dividend yield %1.00-  
Book value per share (Unadj.) Rs23.11.9 1,237.0%  
Shares outstanding (eoy) m10.965.89 186.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.90-  
Avg P/E ratio x12.4-38.6 -32.1%  
P/CF ratio (eoy) x8.8-39.6 -22.1%  
Price / Book Value ratio x2.23.6 60.5%  
Dividend payout %12.40-   
Avg Mkt Cap Rs m54739 1,391.4%   
No. of employees `000NANA-   
Total wages/salary Rs m441 5,130.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m5880-  
Other income Rs m121 1,040.9%   
Total revenues Rs m6001 52,200.0%   
Gross profit Rs m54-2 -2,529.7%  
Depreciation Rs m180 61,266.7%   
Interest Rs m30 14,050.0%   
Profit before tax Rs m44-1 -4,354.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m00-   
Profit after tax Rs m44-1 -4,320.6%  
Gross profit margin %9.10- 
Effective tax rate %0.80 2,020.7%   
Net profit margin %7.50- 
BALANCE SHEET DATA
Current assets Rs m5312 23,175.5%   
Current liabilities Rs m4250 151,807.1%   
Net working cap to sales %18.00- 
Current ratio x1.28.2 15.3%  
Inventory Days Days00- 
Debtors Days Days1,8730- 
Net fixed assets Rs m2198 2,799.9%   
Share capital Rs m3965 60.0%   
"Free" reserves Rs m214-54 -393.9%   
Net worth Rs m25311 2,301.8%   
Long term debt Rs m380-   
Total assets Rs m75010 7,415.1%  
Interest coverage x16.8-50.0 -33.6%   
Debt to equity ratio x0.10-  
Sales to assets ratio x0.80-   
Return on assets %6.3-9.9 -63.0%  
Return on equity %17.4-9.3 -187.9%  
Return on capital %16.2-9.1 -177.9%  
Exports to sales %00-  
Imports to sales %00-  
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m00-   
Fx outflow Rs m00-   
Net fx Rs m00-   
CASH FLOW
From Operations Rs m32-1 -2,156.5%  
From Investments Rs m-44-1 3,816.4%  
From Financial Activity Rs m491 7,842.9%  
Net Cashflow Rs m37-2 -1,832.8%  

Share Holding

Indian Promoters % 51.0 42.7 119.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.1 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 49.0 57.3 85.5%  
Shareholders   10,963 6,628 165.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHUKRA PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on RELISH PHARMA vs BACIL PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

RELISH PHARMA vs BACIL PHARMA Share Price Performance

Period RELISH PHARMA BACIL PHARMA S&P BSE HEALTHCARE
1-Day -2.00% 1.95% 1.22%
1-Month 18.32% 43.43% -0.71%
1-Year 528.10% 161.25% 61.88%
3-Year CAGR 229.50% 67.38% 18.17%
5-Year CAGR 114.18% 44.78% 19.80%

* Compound Annual Growth Rate

Here are more details on the RELISH PHARMA share price and the BACIL PHARMA share price.

Moving on to shareholding structures...

The promoters of RELISH PHARMA hold a 51.0% stake in the company. In case of BACIL PHARMA the stake stands at 42.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of RELISH PHARMA and the shareholding pattern of BACIL PHARMA.

Finally, a word on dividends...

In the most recent financial year, RELISH PHARMA paid a dividend of Rs 0.5 per share. This amounted to a Dividend Payout ratio of 12.4%.

BACIL PHARMA paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of RELISH PHARMA, and the dividend history of BACIL PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.